One in three adults may be living with metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as non-alcoholic fatty liver disease (NAFLD)—and most have no idea it's happening. In this episode of The Health Pulse, we explore why fatty liver often develops silently for years while routine blood work, including fasting glucose and HbA1c, continues to appear completely normal.

We begin by looking at the liver as the body's metabolic command center, responsible for managing glucose, storing glycogen, and regulating energy balance. You'll learn how rising insulin after meals normally directs excess glucose into storage, but when glycogen stores become full, the liver begins converting surplus carbohydrates into fat through de novo lipogenesis.

From there, we examine one of the most important—and least understood—concepts in metabolic medicine: selective hepatic insulin resistance. Rather than becoming completely resistant to insulin, the liver develops a paradoxical state in which it continues producing glucose while simultaneously responding to insulin by making even more fat. This metabolic mismatch allows hyperinsulinemia to quietly drive fatty liver years before type 2 diabetes is diagnosed.

We also explain why storing triglycerides inside the liver may initially serve as a protective mechanism, and how prolonged fat accumulation eventually leads to lipotoxicity, oxidative stress, chronic inflammation, fibrosis, and progressive liver injury.

Most importantly, we discuss what can reverse the process. Research consistently shows that modest weight loss—particularly when it reduces visceral fat—can dramatically improve liver health. We also review the evidence supporting Mediterranean-style and lower-carbohydrate eating patterns, along with the powerful role of exercise, which transforms skeletal muscle into an insulin-independent glucose sink, reducing the metabolic burden placed on the liver.

Finally, we highlight the laboratory markers and imaging studies that can identify metabolic dysfunction long before traditional liver tests become abnormal. We discuss fasting insulin, the triglyceride-to-HDL ratio, ApoB, hs-CRP, and advanced imaging tools such as FibroScan and MRI-PDFF, while explaining why ALT and AST are often late indicators of liver disease rather than early warning signs.

If you've ever been told your blood sugar is "normal" while wondering whether your metabolism is truly healthy, this episode offers a deeper understanding of one of the fastest-growing chronic diseases in the world—and how to detect it before permanent damage occurs.

📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required.

📅 Book your appointment or learn more at:
👉 Quick Lab Mobile
📧 Contact us: info@quicklabmobile.com

💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. 

Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.